English | Español
Patient Daily | Feb 23, 2026

Study finds low COVID-19 and flu vaccination rates among pregnant women in Norway
Patient Daily | Feb 23, 2026

AI-driven DeepRare system shows promise for faster rare disease diagnosis
Patient Daily | Feb 23, 2026

Study links infant sensory sensitivity with reduced quality of deep sleep
Patient Daily | Feb 23, 2026

Gut microbiome analysis may help identify severe insulin resistance in type 2 diabetes
Patient Daily | Feb 23, 2026

CDC postpones key vaccine advisory panel meeting amid leadership turnover
Patient Daily | Feb 23, 2026

U.S. biopharma faces policy crossroads amid rising global competition
Patient Daily | Feb 23, 2026

FDA faces scrutiny after refusing review of Moderna mRNA flu vaccine
Patient Daily | Feb 23, 2026

Shorter critical anti-junk food ads reduce adult cravings more effectively

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'